Cue Biopharma (CUE) Invested Capital (2017 - 2025)
Historic Invested Capital for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $14.7 million.
- Cue Biopharma's Invested Capital fell 4423.12% to $14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.7 million, marking a year-over-year decrease of 4423.12%. This contributed to the annual value of $21.8 million for FY2024, which is 4686.14% down from last year.
- Per Cue Biopharma's latest filing, its Invested Capital stood at $14.7 million for Q3 2025, which was down 4423.12% from $20.6 million recorded in Q2 2025.
- Over the past 5 years, Cue Biopharma's Invested Capital peaked at $73.7 million during Q4 2022, and registered a low of $10.0 million during Q1 2025.
- Its 5-year average for Invested Capital is $46.4 million, with a median of $52.0 million in 2023.
- Per our database at Business Quant, Cue Biopharma's Invested Capital surged by 5401.23% in 2021 and then plummeted by 6987.11% in 2025.
- Cue Biopharma's Invested Capital (Quarter) stood at $65.5 million in 2021, then increased by 12.51% to $73.7 million in 2022, then plummeted by 44.24% to $41.1 million in 2023, then plummeted by 46.86% to $21.8 million in 2024, then plummeted by 32.65% to $14.7 million in 2025.
- Its Invested Capital was $14.7 million in Q3 2025, compared to $20.6 million in Q2 2025 and $10.0 million in Q1 2025.